Orthopedic Biomaterials Market Size Surpass US$ 40.65 Bn By 2032

The global orthopedic biomaterials market size is projected to surpass around US$ 40.65 bn by 2032 from USD 20 billion in 2022 with a CAGR of 9.83% from 2023 to 2032.

Table of Contents

Key Takeaways

North America dominated the global market with the highest market share in 2022.
Asia-Pacific is expected to expand at the largest CAGR between 2023 and 2032.
By Material, the ceramics & bioactive glass segment dominated the market in 2022.
By Application, the orthopedic implant segment dominated the global orthopedic biomaterials market in 2022.

Orthopedic biomaterials are natural or synthetic material used to replace an organ in the human body. They are generally required in surgical implants, orthopedics, prosthetics and others. Various biomaterial based medical devices comprise stents, heart walls, hip joints, artificial knee, etc. Biomaterials aid in the innovations of regenerative medicines.

These products are customized to perform numerous biological functions by repairing certain tissues in the human body. For instance, the orthopedic biomaterials are used for joint reconstruction, spine implants, bio resorbable tissue fixation and orthobiologics. In several regions such as North America, Asia, and Japan the government regulated the use of biomaterials which are of high quality. The biomaterials are implanted into human body hence would require safety and efficiency approval for marketing. Further, as these biomaterials are implanted in the human body, they should be biocompatible and must pass the ISO biocompatibility testing standards.

Get the Sample Pages of Report for More Understanding@ https://www.precedenceresearch.com/sample/1107

Growth Factors

Growing prevalence of musculoskeletal diseases and disorders are the key driving factors for the growth of orthopedic biomaterials market. The reason for the occurrences of musculoskeletal disorder is orthopedic trauma or injury which affect the muscles, ligaments, tendons, bone and nervous. The orthopedic trauma affects the musculoskeletal systems. Increasing usage of nanoparticles in to orthopedic bioimplant will further propel the growth of the market. Currently, R&D activities into in the healthcare sector continuously focus to develop the treatment, therapies and medications for degenerative diseases. One of the crucial influences for the market growth is changing consumer preferences from traditional materials to nanophase materials. Considerable benefits of biomaterials led substantial inventions in the regenerative medicines sector in the past couple of years. Increasing awareness among young generations towards health care and increasing geriatric population is expected to boost the growth of the orthopedic biomaterials market. Additionally, increasing demand for medical implant, substantial growth in the cardiovascular diseases escalates the growth of the market. However, procedure of manufacturing biomaterials is very time consuming and must go through biocompatibility testing and clinical trials which hampers the market growth. Nonetheless, growth in the adoption of implantable devices, increasing patient population and availability of flexible government regulations in the emerging region is projected to offer significant growth avenues for orthopedic biomaterials market over the forecast period.

Orthopedic Biomaterials Market Scope

Report Highlights	Details
Market Size in 2023	USD 21.38 Billion
Market Size by 2032	USD 40.65 Billion
Growth Rate from 2023 to 2032	CAGR of 7.4%
Largest Market	North America
Fastest Growing Market	Asia Pacific
Base Year	2022
Forecast Period	2023 to 2032
Segments Covered	Material, Application, End User, Region

Regional Snapshots

Regionally, the orthopedic biomaterials market has been segmented into North America, Europe, Asia Pacific, Middle East & Africa. North America dominated global orthopedic biomaterials market in 2019 owing to increasing demand for technologically advanced orthopedic implants. North America is projected to further mirror this trend throughout the prediction period. As per National Health Statistics Report, 209 million Americans participated in sports and fitness activity in 2013, which is increased up to 213 million 2015. This has resulted in increased number of orthopedic surgeries including joint reconstruction, joint arthroplasty and viscoupllementation.

Europe closely followed North America owing to cumulative orthopedic surgery cases and increasing focus on health care. Lack of awareness and availability of treatment facilities in the Middle East and Africa witness the slow growth in the orthopedic biomaterials market.

Asia Pacific is expected to record the highest CAGR over the forecast period. Growing healthcare industry in Japan, budding demand for cosmetic and plastic surgeries in India and less stringent tax policy in China and escalating elderly population drives the orthopedic biomaterials market significantly in this region.

Report Highlights

Companies involved in the marketplace are focusing on developing innovative orthopedic biomaterials at competitive prices.
The arrival of 3D printing is projected to substantially enhance the demand for orthopedic biomaterials due to benefits coupled with fabricating scaffolds.
Increasing prevalence of bone degenerative diseases and bone disorders in low- and middle-income countries drives the regional market growth.
Significant average selling price of the orthopedic implants, favorable coverage of orthopedic procedure and growing demand for technologically advanced orthopedic implants from surgeons with enhanced lifetime and quality flourishes the growth in developed region.

Key Players & Strategies

Major players in orthopedic biomaterials are Acumed, LLC. Medtronic plc, Globus Medical, Inc., Stryker Corporation, Koninklijke DSM N.V., Exactech, Inc., Johnson & Johnson, Zimmer Biomet, Wright Medical Group, Inc., and NuVasive, Inc. among others. In July 2020, Medtronic plc, a global leader in medical technology acquired Medicrea. This acquisition would strengthen the Medtronic’s position as global innovator in enabling technologies and solutions for the spine surgery. Stryker acquired Mako Surgical Corp. in order to construct total knee and total hip replacement robotic products. Further, in year 2016, Zimmer Biomet acquired LDR Holdings to make their spine segment stronger and enhance growth of its sports medicine segment.